- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06388044
ACT for Infertility: Case Series
Acceptance and Commitment Therapy for Infertility Patients: A Case Series
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In this study, the investigators present Acceptance and Commitment Therapy (ACT) as a potentially well-suited intervention for infertility patients, and they highlight mechanisms and processes through which ACT might benefit patients. They present a series of cases in which the therapist uses an ACT approach to treat individuals diagnosed with infertility.
The Duke University Health System includes a fertility clinic, which houses an embedded clinical psychology team. Patients at the fertility center can participate in individual psychotherapy and/ or group psychotherapy as part of their fertility treatment. An interventionist will provide psychotherapy to up to 10 individuals on the therapy waitlist. Patients will be eligible for the study if they: are at least 18 years old, have a diagnosis of infertility, speak English, and are not already participating in individual therapy. Patients will be excluded from the study if they endorse current suicidality and/ or self-harming behavior, current psychosis symptoms, and/ or current substance use.
For those that enroll in the study, patients will complete 12 therapy sessions in the fertility clinic, with sessions lasting between 50 and 60 minutes. Although sessions will vary across individuals, the therapist will aim to target the six core ACT processes in all cases. The therapist will offer both in-person and virtual sessions. Participants will complete a subset of questionnaires at each study session.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Francesca Scheiber, PhD
- Phone Number: 9196688696
- Email: fs158@duke.edu
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27705
- Duke North Pavilion
-
Contact:
- Francesca Scheiber, PhD
- Phone Number: 919-668-8696
- Email: fs158@duke.edu
-
Sub-Investigator:
- Julia Woodward, PhD
-
Sub-Investigator:
- Ashley Moskovich, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria: Patients will be eligible if they
- are at least 18 years old
- have a diagnosis of infertility
- speak English
- are not already participating in individual therapy.
Exclusion Criteria: Patients will be excluded from the study if they
- endorse current suicidality and/ or self-harming behavior
- current psychosis symptoms
- and/ or current substance use
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Acceptance and Commitment Therapy
For those that enroll in the study, the therapist will see patients for 12 therapy sessions in the fertility clinic, with sessions lasting between 50 and 60 minutes.
The therapist will offer both in-person and virtual sessions.
|
Acceptance and Commitment Therapy (ACT) is a third-wave cognitive behavioral therapy.
ACT aims to increase psychological flexibility through six core processes: acceptance, cognitive defusion, present-moment awareness, self as context, values, and committed action.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Acceptability of the Intervention
Time Frame: Week 6 (Session 6) and week 12 (Session 12).
|
Patients will answer several questions about the extent to which they perceive the intervention to be beneficial and acceptable.
Patients will answer questions using a 5-point Likert scale, with 1 being 'strongly disagree' and 5 being 'strongly agree.'
The investigators will use this information descriptively--for each question, they will describe patient responses by identifying the percentage of patients that responded with each option (e.g., 7 out of 10 patients indicated that they strongly agreed with the following question: [question]).
|
Week 6 (Session 6) and week 12 (Session 12).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Fertility Problem Inventory (FPI)
Time Frame: Week 1 (Session 1), week 6 (Session 6), and week 12 (session 12).
|
The FPI is a 46-item self-report questionnaire that measures infertility-related stress.
It includes a global stress score, as well as additional scores for four constructs: social concern, sexual concern, relationship concern, and need for parenthood.
Patients will answer questions using a scale of 1 to 6, with higher scores reflecting greater distress.
|
Week 1 (Session 1), week 6 (Session 6), and week 12 (session 12).
|
Change in Patient Health Questionnaire 9 (PHQ-9)
Time Frame: PHQ-9: Week 1 (Session 1), week 6 (Session 6), and week 12 (session 12).
|
The PHQ-9 is a 9-item self-report questionnaire that measures symptoms of depression.
Participants answer questions using a scale of 0 to 3, with higher scores reflecting more and/ or more severe depression symptoms.
|
PHQ-9: Week 1 (Session 1), week 6 (Session 6), and week 12 (session 12).
|
Change in Patient Health Questionnaire 2 (PHQ-2)
Time Frame: PHQ-2: Weeks 2 (Session 2), 3 (Session 3), 4 (Session 4), 5 (Session 5), 7 (Session 7), 8 (Session 8), 9 (Session 9), 10 (Session 10), and 11 (Session 11).
|
The PHQ-2 is a 2-item self-report questionnaire that measures symptoms of depression.
Participants answer questions using a scale of 0 to 3, with higher scores reflecting more and/ or more severe depression symptoms.
|
PHQ-2: Weeks 2 (Session 2), 3 (Session 3), 4 (Session 4), 5 (Session 5), 7 (Session 7), 8 (Session 8), 9 (Session 9), 10 (Session 10), and 11 (Session 11).
|
Change in Generalized Anxiety Disorder Questionnaire 7 (GAD-7)
Time Frame: GAD-7: Week 1 (Session 1), week 6 (Session 6), and week 12 (session 12).
|
The GAD-7 is a 7-item self-report questionnaire that measures symptoms of generalized anxiety.
Participants answer questions using a scale of 0 to 3, with higher scores reflecting more and/ or more severe anxiety symptoms.
|
GAD-7: Week 1 (Session 1), week 6 (Session 6), and week 12 (session 12).
|
Change in Generalized Anxiety Disorder Questionnaire 2 (GAD-2)
Time Frame: GAD-2: Weeks 2 (Session 2), 3 (Session 3), 4 (Session 4), 5 (Session 5), 7 (Session 7), 8 (Session 8), 9 (Session 9), 10 (Session 10), and 11 (Session 11).
|
The GAD-2 is a 2-item self-report questionnaire that measures symptoms of generalized anxiety.
Participants answer questions using a scale of 0 to 3, with higher scores reflecting more and/ or more severe anxiety symptoms.
|
GAD-2: Weeks 2 (Session 2), 3 (Session 3), 4 (Session 4), 5 (Session 5), 7 (Session 7), 8 (Session 8), 9 (Session 9), 10 (Session 10), and 11 (Session 11).
|
Change in Modified Differential Emotions Scale (mDES)
Time Frame: Week 1 (Session 1), week 6 (Session 6), and week 12 (session 12).
|
The mDES is a 20-item self-report questionnaire that measures the extent to which one has felt a range of emotions, including both negative and positive emotions.
It includes a positive emotions score and a negative emotions score.
Participants answer questions on a scale of 0 to 4, with higher scores reflecting more of that type of emotion.
|
Week 1 (Session 1), week 6 (Session 6), and week 12 (session 12).
|
Change in Comprehensive Assessment of Acceptance and Commitment Therapy (CompACT-15)
Time Frame: Week 1 (Session 1), week 3 (Session 3), week 6 (Session 6), week 9 (Session 9), and week 12 (Session 12).
|
The CompACT-15 is a 15-item self-report questionnaire that measures several components of psychological flexibility, including openness to experience, behavioral awareness, and valued action.
Patients will answer questions using a scale of 0 to 6, with higher scores reflecting greater levels of psychological flexibility.
|
Week 1 (Session 1), week 3 (Session 3), week 6 (Session 6), week 9 (Session 9), and week 12 (Session 12).
|
Change in Intolerance of Uncertainty (IUS)
Time Frame: Week 1 (Session 1), week 3 (Session 3), week 6 (Session 6), week 9 (Session 9), and week 12 (Session 12).
|
The IUS is a 27-item self-report questionnaire that measures emotional, cognitive, and behavioral reactions to uncertainty, the consequences of uncertainty, and attempts to control the future.
Patients will answer questions using a scale of 1 to 5, with higher scores reflecting greater levels of intolerance.
|
Week 1 (Session 1), week 3 (Session 3), week 6 (Session 6), week 9 (Session 9), and week 12 (Session 12).
|
Change in Valuing Questionnaire (VQ)
Time Frame: Week 1 (Session 1), week 3 (Session 3), week 6 (Session 6), week 9 (Session 9), and week 12 (Session 12).
|
The VQ is a 10-item self-report questionnaire that measures the consistency with which an individual's behavior is aligned with his or her values.
The VQ includes two constructs: progress and obstruction.
Participants will answer questions using a scale of 0 to 6. On the progress subscale, higher scores reflect a greater level of consistency between one's values and behavior.
On the obstruction subscale, higher scores reflect a greater level of inconsistency between one's values and behavior.
|
Week 1 (Session 1), week 3 (Session 3), week 6 (Session 6), week 9 (Session 9), and week 12 (Session 12).
|
Change in Values-Based Behavior
Time Frame: All sessions, weeks 1-12.
|
Measured by self-reported values of importance.
|
All sessions, weeks 1-12.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Rhonda Merwin, PhD, Duke University
Publications and helpful links
General Publications
- Bright K, Dube L, Hayden KA, Gordon JL. Effectiveness of psychological interventions on mental health, quality of life and relationship satisfaction for individuals and/or couples undergoing fertility treatment: a systematic review and meta-analysis protocol. BMJ Open. 2020 Jul 19;10(7):e036030. doi: 10.1136/bmjopen-2019-036030.
- Cunha M, Galhardo A, Pinto-Gouveia J. Experiential avoidance, self-compassion, self-judgment and coping styles in infertility. Sex Reprod Healthc. 2016 Dec;10:41-47. doi: 10.1016/j.srhc.2016.04.001. Epub 2016 Apr 8.
- Doyle, M., & Carballedo, A. (2014). Infertility and mental health. Advances in psychiatric treatment, 20(5), 297-303.
- Dube L, Bright K, Hayden KA, Gordon JL. Efficacy of psychological interventions for mental health and pregnancy rates among individuals with infertility: a systematic review and meta-analysis. Hum Reprod Update. 2023 Jan 5;29(1):71-94. doi: 10.1093/humupd/dmac034.
- Dube L, Nkosi-Mafutha N, Balsom AA, Gordon JL. Infertility-related distress and clinical targets for psychotherapy: a qualitative study. BMJ Open. 2021 Nov 9;11(11):e050373. doi: 10.1136/bmjopen-2021-050373.
- Hayes-Skelton, S. A., & Eustis, E. H. (2020). Experiential avoidance.
- Hayes, S. C., & Hofmann, S. G. (2018). Future directions in CBT and Evidence-based therapy. Process-based CBT: The science and core clinical competencies of cognitive behavioral therapy, 427-435.
- Peterson, B. D., & Eifert, G. H. (2011). Using acceptance and commitment therapy to treat infertility stress. Cognitive and Behavioral Practice, 18(4), 577-587.
- Schuette SA, Andrade FC, Woodward JT, Smoski MJ. Identifying modifiable factors associated with psychological health in women experiencing infertility. J Health Psychol. 2023 Oct;28(12):1143-1156. doi: 10.1177/13591053231185549. Epub 2023 Jul 4.
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PRO00115010
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Wake Forest University Health SciencesWithdrawnUterine Diseases | Endometriosis | Infertility Unexplained | Endometrial Diseases | Infertility; Female, NonimplantationUnited States
-
Istanbul University - Cerrahpasa (IUC)RecruitingInfertility | Sexual Dysfunction | Infertility, Male | Nurse's Role | Sexuality | Infertility; FemaleTurkey
Clinical Trials on Acceptance and Commitment Therapy
-
Francisco Garcia TorresUniversidad de CórdobaRecruiting
-
Anne Roche, MACompletedQuality of Life | AgingUnited States
-
University of CoimbraUnknown
-
Dana-Farber Cancer InstituteCompleted
-
Skane University HospitalRecruiting
-
Saglik Bilimleri UniversitesiRecruitingPsychotic Disorders | Acceptance and Commitment Therapy | Psychiatric NursingTurkey
-
Mustafa Kemal UniversityEnrolling by invitation
-
University of New MexicoUniversity of Kansas Medical Center; University of North Carolina, Chapel Hill and other collaboratorsCompletedChronic Pain | Opioid Use | Acceptance and Commitment TherapyUnited States
-
Uppsala UniversityCompletedVulvodynia, Generalized | Provoked VestibulodyniaSweden
-
University of NottinghamNottinghamshire Healthcare NHS TrustCompletedDementia | Acceptance and Commitment TherapyUnited Kingdom